Fresenius SE KGaA (Fresenius SE KGaA) ROCE % : 1.88% (As of Dec. 2023)

View and export this data going back to 2011. Start your Free Trial

What is Fresenius SE KGaA ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Fresenius SE KGaA's annualized ROCE % for the quarter that ended in Dec. 2023 was 1.88%.

Fresenius SE KGaA ROCE % Historical Data

The historical data trend for Fresenius SE KGaA's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fresenius SE KGaA ROCE % Chart

Fresenius SE KGaA Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

9.82

8.78

7.48

3.15

2.58

Fresenius SE KGaA Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %	Get a 7-Day Free Trial															3.01	5.13	3.61	2.58	1.88

Fresenius SE KGaA ROCE % Calculation

Fresenius SE KGaA's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	1362.05	/	( ( (80932.203 - 14468.22)	+	(49382.77 - 10174.482) )	/ 2 )
	=	1362.05	/	( (66463.983	+	39208.288)	/ 2 )
	=	1362.05	/	52836.1355
	=	2.58 %

Fresenius SE KGaA's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	833.152	/	( ( (80392.743 - 31151.547)	+	(49382.77 - 10174.482) )	/ 2 )
	=	833.152	/	( ( 49241.196	+	39208.288 )	/ 2 )
	=	833.152	/	44224.742
	=	1.88 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

Fresenius SE KGaA (OTCPK:FSNUY) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Fresenius SE KGaA ROCE % Related Terms

Thank you for viewing the detailed overview of Fresenius SE KGaA's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Fresenius SE KGaA (Fresenius SE KGaA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Fresenius SE & Co KGaA (OTCPK:FSNUY) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

FSNUF:USA FREN:Mexico FRE:Italy FREd:UK 0OO9:UK FRE:Germany FRE:Austria

Address

Else-Kroener-Strasse 1, Bad Homburg, HE, DEU, 61352

Website

https://www.fresenius.com

Fresenius SE is a healthcare holding company based in Germany with four segments. The company owns a large stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals and fertility clinics in Germany, Spain, and Latin America. Vamed provides a variety of services such as healthcare facility construction and operation management, including post-acute care rehabilitation.

Fresenius SE KGaA (Fresenius SE KGaA) Headlines

From GuruFocus

Top 1st-Quarter Trades of the Tweedy Browne Global Value Fund

By Margaret Moran Margaret Moran • 04-13-2021

Tweedy Browne Comments on Fresenius

By Sydnee Gatewood Sydnee Gatewood • 06-01-2021

Tweedy Brown Comments on Fresenius

By Sydnee Gatewood Sydnee Gatewood • 05-04-2021

Fresenius SE KGaA Stock Is Estimated To Be Fairly Valued

By GF Value • 07-02-2021

Fresenius SE KGaA Stock Is Believed To Be Modestly Undervalued

By GF Value GF Value • 04-01-2021

Tweedy Browne Fund's 1st-Quarter Commentary

By Sydnee Gatewood Sydnee Gatewood • 05-04-2021

Fresenius SE & Co. KGaA to present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference on 13 November 2019

By PRNewswire PRNewswire • 11-07-2019